Russell Investments Group, Ltd. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 46 filers reported holding PSYCHEMEDICS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2019$19,000
-34.5%
1,852
-10.4%
0.00%
Q1 2019$29,000
-3.3%
2,066
+9.3%
0.00%
Q4 2018$30,000
-16.7%
1,8910.0%0.00%
Q3 2018$36,0000.0%1,8910.0%0.00%
Q2 2018$36,000
-10.0%
1,891
-2.1%
0.00%
Q1 2018$40,000
+2.6%
1,9310.0%0.00%
Q4 2017$39,000
-81.4%
1,931
-83.1%
0.00%
Q3 2017$210,000
-32.9%
11,401
-9.2%
0.00%
-100.0%
Q2 2017$313,000
+10.2%
12,550
-11.3%
0.00%0.0%
Q1 2017$284,000
-4.4%
14,150
+14.4%
0.00%0.0%
Q4 2016$297,00012,3680.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 250,388$3,974,0004.46%
QUANTUM CAPITAL MANAGEMENT 63,246$1,004,0000.58%
Mill Road Capital Management LLC 14,896$236,0000.30%
Gs Investments, Inc. 15,800$250,746,0000.21%
RBF Capital, LLC 87,917$1,395,0000.18%
North Star Investment Management Corp. 85,282$1,353,0000.18%
CRAWFORD INVESTMENT COUNSEL INC 297,675$4,724,0000.16%
Uniplan Investment Counsel, Inc. 145,677$2,311,0000.16%
DEPRINCE RACE & ZOLLO INC 282,186$4,478,0000.13%
Moors & Cabot, Inc. 37,932$605,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders